Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Shuying XuDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0003-4572-8663
Shumin TanDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0003-1093-2576
Patricia RomanosDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Jennifer L ReedyDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Yihan ZhangMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Michael K MansourDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0001-8892-8695
Jatin M VyasDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-9985-9565
Joan MecsasDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0001-9455-6672
Hongmei MouMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
John M LeongDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0003-0240-6402
Funding
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Dissecting Yersinia Yop Targets in NeutrophilsR01AI169786 · NIAID · TUFTS UNIVERSITY BOSTON · PI Joan C Mecsas · 2022 to 2026
$3.6M
Features of PMN Senescence that Lead to Susceptibility to Pneumococcal InfectionR21AG071268 · NIA · TUFTS UNIVERSITY BOSTON · PI LEONG, JOHN M, MECSAS, JOAN C · 2021 to 2022
$469k
Host Responses to Coccidioides by Human Airway EpitheliumR21AI152499 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI VYAS, JATIN M · 2022 to 2023
$462k
SURVIVAL OF PRIMARILY VASCULARIZED MURINE ALLOGRAFTSR01AI015081 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BURDICK, JAMES F · 1985 to 1989
–
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI15081,AI152499HHS | NIH | National Institute on Aging (NIA) AG071268NIAID NIH HHS R01 AI169786NIAID NIH HHS R21 AI152499NIA NIH HHS R21 AG071268NIDDK NIH HHS P30 DK043351
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.